L-Arginine infusion during resuscitation for hemorrhagic shock: Impact and mechanism

Journal of Trauma and Acute Care Surgery

Volumn 72, Issue 2, 2012, Pages 397-402

  Arora, Tania K ^a   Malhotra, Ajai K ^a   Ivatury, Rao ^a   Mangino, Martin J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hemorrhage; L Arginine; L NAME; Nitric oxide; Nitric oxide synthetase; Shock

Indexed keywords

ARGININE; DEXTRO ARGININE; LACTIC ACID; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; LACTIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CELL INFILTRATION; CELL LOSS; CONTROLLED STUDY; CRYPT CELL; EPITHELIUM CELL; FLUID RESUSCITATION; HEMORRHAGIC SHOCK; HISTOLOGY; MALE; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SURVIVAL; ANALYSIS OF VARIANCE; ANIMAL; BLOOD; HEMODYNAMICS; METHODOLOGY; NONPARAMETRIC TEST; PATHOLOGY; RANDOMIZATION; RESUSCITATION; SMALL INTESTINE; SPRAGUE DAWLEY RAT; SURVIVAL RATE;

ANALYSIS OF VARIANCE; ANIMALS; ARGININE; HEMODYNAMICS; INTESTINE, SMALL; LACTATES; NG-NITROARGININE METHYL ESTER; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; RESUSCITATION; SHOCK, HEMORRHAGIC; STATISTICS, NONPARAMETRIC; SURVIVAL RATE;

EID: 84860566335     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0b013e3181d039fd     Document Type: Article

References (36)

1. Jones AS, Kaufman LS, Slakever DS. Cost of Injury in the United States, A Report to Congress. MD: The Johns Hopkins University; 1989.
2. Rotstein OD. Modeling the two-hit hypothesis for evaluating strategies to prevent organ injury after shock/resuscitation. J Trauma. 2003;54: S203-S206.
3. Holecroft J, Anderson J, Sena M. Shock, ACS Surgery: Principles of Practice. WebMD; 2006. Available at http://www.acssurgery.com.
4. Manikis P, Jankowski S, Zhang H, Kahn RJ, Vincent JL. Correlation of serial blood lactate levels to organ failure and mortality after trauma. Am J Emerg Med. 1995;13:619-622.
5. Porter JM, Ivatury RR. In search of the optimal end points of resuscitation in trauma patients: a review. J Trauma. 1998;44:908-914.
6. Zhong Z, Wheeler MD, Li X, et al. L-Glycine: a novel antiinflammatory, immunomodulatory, and cytoprotective agent. Curr Opin Clin Nutr Metab Care. 2003;6:229-240.
7. Albina JE, Reichner JS. Nitric oxide in inflammation and immunity. New Horiz. 1995;3:46-64.
8. Fukuto JM, Mayer B. The enzymology of nitric oxide synthetase. In: Freelisch M, Stamler JS, eds. Methods in Nitric Oxide Research. New York: Wiley; 1998:147-161.
9. Angele MK, Fitzal F, Smail N, et al. L-Arginine attenuates traumahemorrhage-induced liver injury. Crit Care Med. 2000;28:3242-3248.
10. Angele MK, Smail N, Wang P, Cioffi WG, Bland KI, Chaudry IH. L-Arginine restores the depressed cardiac output and regional perfusion after trauma-hemorrhage. Surgery. 1998;124:394-401.
11. Angele MK, Smail N, Knoferl MW, Ayala A, Cioffi WG, Chaudry IH. L-Arginine restores splenocyte functions after trauma and hemorrhage potentially by improving splenic blood flow. Am J Physiol. 1999;276:C145-C151.
12. Isidori A, Lo MA, Cappa M. A study of growth hormone release in man after oral administration of amino acids. Curr Med Res Opin. 1981;7:475-481.
13. Miyabe M, Yanagi K, Ohshima N, Sato S, Fukuda T, Toyooka H. Sodium nitroprusside decreases leukocyte adhesion and emigration after hemorrhagic shock. Anesth Analg. 2002;94:296-301, table.
14. Sato S, Suzuki A, Nakajima Y, Iwamoto T, Bito H, Miyabe M. S-Nitroso-N-acetylpenicillamine (SNAP) during hemorrhagic shock improves mortality as a result of recovery from vascular hyporeactivity. Anesth Analg. 2000;90:362-368.
15. Youn TJ, Kim HS, Kang HJ, et al. Inhibition of nitric oxide synthesis increases apoptotic cardiomyocyte death and myocardial angiotensinconverting enzyme gene expression in ischemia/reperfusion-injured myocardium of rats. Heart Vessels. 2001;16:12-19.
16. Mangino MJ, Anderson CB, Murphy MK, Brunt E, Turk J. Mucosal arachidonate metabolism and intestinal ischemia-reperfusion injury. Am J Physiol. 1989;257:G299-G307.
17. Vatner SF. Effects of hemorrhage on regional blood flow distribution in dogs and primates. J Clin Invest. 1974;54:225-235.
18. Race D, Cooper E, Rosenbaum M. Hemorrhagic shock: the effect of prolonged low flow on the regional distribution of blood and its modification by hypothermia. Ann Surg. 1968;167:454-466.
19. Nanobashvili J, Neumayer C, Fuegl A, et al. Development of 'no-reflow' phenomenon in ischemia/reperfusion injury: failure of active vasomotility and not simply passive vasoconstriction. Eur Surg Res. 2003;35: 417-424.
20. Behmanesh S, Kempski O. Mechanisms of endothelial cell swelling from lactacidosis studied in vitro. Am J Physiol Heart Circ Physiol. 2000;279:H1512-H1517.
21. Kretschmar K, Engelhardt T. Swelling of capillary endothelial cells contributes to traumatic hemorrhagic shock-induced microvascular injury: a morphologic and morphometric analysis. Int J Microcirc Clin Exp. 1994;14:45-49.
22. Kaminski KA, Bonda TA, Korecki J, Musial WJ. Oxidative stress and neutrophil activation - the two keystones of ischemia/reperfusion injury. Int J Cardiol. 2002;86:41-59.
23. Daughters K, Waxman K, Nguyen H. Increasing nitric oxide production improves survival in experimental hemorrhagic shock. Resuscitation. 1996;31:141-144.
24. Biffl WL, Moore EE, Moore FA, Barnett C. Nitric oxide reduces endothelial expression of intercellular adhesion molecule (ICAM)-1. J Surg Res. 1996;63:328-332.
25. Symington PA, Ma XL, Lefer AM. Protective actions of S-nitroso- Nacetylpenicillamine (SNAP) in a rat model of hemorrhagic shock. Methods Find Exp Clin Pharmacol. 1992;14:789-797.
26. Vukosavljevic N, Jaron D, Barbee KA, Buerk DG. Quantifying the L-arginine paradox in vivo. Microvasc Res. 2006;71:48-54.
27. Boger RH. Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond. Ann Med. 2006;38:126-136.
28. Millatt LJ, Whitley GS, Li D, et al. Evidence for dysregulation of dimethylarginine dimethylaminohydrolase I in chronic hypoxia-induced pulmonary hypertension. Circulation. 2003;108:1493-1498.
29. Mangino MJ, Murphy MK, Grabau GG, Anderson CB. Protective effects of glycine during hypothermic renal ischemia-reperfusion injury. Am J Physiol. 1991;261:F841-F848.
30. Nishimura Y, Lemasters JJ. Glycine blocks opening of a death channel in cultured hepatic sinusoidal endothelial cells during chemical hypoxia. Cell Death Differ. 2001;8:850-858.
31. Mangino JE, Kotadia B, Mangino MJ. Characterization of hypothermic intestinal ischemia-reperfusion injury in dogs. Effects of glycine. Transplantation. 1996;62:173-178.
32. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA. 1991;88:4651-4655.
33. Lefer AM. Interaction between myocardial depressant factor and vasoactive mediators with ischemia and shock. Am J Physiol. 1987;252:R193-R205.
34. Lillehei RC. The intestinal factor in irreversible hemorrhagic shock. Surgery. 1957;42:1043-1054.
35. Vallance P, Leone A, Calver A, Collier J, Moncada S. Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J Cardiovasc Pharmacol. 1992;20(suppl 12):S60-S62.
36. Nijveldt RJ, Teerlink T, Van Der HB, et al. Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality. Clin Nutr. 2003;22:23-30.